Literature DB >> 7895811

cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle.

J E Springer1, J L Seeburger, J He, A Gabrea, E P Blankenhorn, L W Bergman.   

Abstract

Total RNA from rat Schwann cells grown in culture and adult rat skeletal muscle was reverse transcribed, amplified for glial cell line-derived neurotrophic factor (GDNF) messenger RNA (mRNA) using the polymerase chain reaction (PCR), and the PCR products sequenced. Two forms of GDNF were detected in the PCR step, one of a predicted size (GDNF633) and a second smaller form missing a 78-base pair sequence (GDNF555). Sequence analysis demonstrated that GDNF633 is similar to the published sequence of GDNF differing only at three nucleotides. Southern and Northern blot analyses reveal that the two forms are probably derived from a single RNA species that is alternatively spliced. Interestingly, GDNF633 mRNA was found to be selectively upregulated in denervated rat skeletal muscle at 1-2 weeks following axotomy, providing evidence that the innervation status of the muscle may determine the expression profile of the two alternatively spliced forms. Given these findings, we suggest that GDNF may function as a target-derived trophic factor for neuronal populations innervating skeletal muscle, including sensory neurons and spinal cord motoneurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895811     DOI: 10.1016/0014-4886(95)90006-3

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  25 in total

1.  Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases.

Authors:  M Yamamoto; N Mitsuma; A Inukai; Y Ito; M Li; T Mitsuma; G Sobue
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

Review 2.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.

Authors:  S Hunot; V Bernard; B Faucheux; F Boissière; E Leguern; C Brana; P P Gautris; J Guérin; B Bloch; Y Agid; E C Hirsch
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Effects of acetylcholine and electrical stimulation on glial cell line-derived neurotrophic factor production in skeletal muscle cells.

Authors:  John-Mary Vianney; Damon A Miller; John M Spitsbergen
Journal:  Brain Res       Date:  2014-09-16       Impact factor: 3.252

6.  Neurotrophin Regulation and Signaling in Airway Smooth Muscle.

Authors:  Benjamin B Roos; Jacob J Teske; Sangeeta Bhallamudi; Christina M Pabelick; Venkatachalem Sathish; Y S Prakash
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues.

Authors:  M Yamamoto; G Sobue; K Yamamoto; S Terao; T Mitsuma
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

Review 8.  The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.

Authors:  Eroboghene E Ubogu
Journal:  J Vasc Res       Date:  2013-07-06       Impact factor: 1.934

9.  Glial cell line-derived neurotrophic factor (GDNF) expression and NMJ plasticity in skeletal muscle following endurance exercise.

Authors:  A M Gyorkos; M J McCullough; J M Spitsbergen
Journal:  Neuroscience       Date:  2013-11-08       Impact factor: 3.590

Review 10.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.